Cervical cancer trials in Austria

3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

  Where

  Graz, Innsbruck, Salzburg, Vienna

  Age

  18 years and over

  People

  1,023 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07216703 · EU 2025-521514-26-00
• Phase 3Taking people
  Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy

  Where

  Feldkirch, Graz, Leoben, St. Poelten, Vienna

  Age

  18 years to 85 years

  People

  514 worldwide

  Run by

  The Central and Eastern European Gynecologic Oncology Group

  See details and how to joinNCT04989647 · EU 2023-504973-19-01
• Phase 2Taking people
  Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer

  Where

  Vienna

  Age

  18 years to 99 years

  People

  1,000

  Run by

  Medical University of Vienna

  See details and how to joinNCT03617133